Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. 1994

M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
First Department of Internal Medicine, Hiroshima University School of Medicine, Japan.

OBJECTIVE We investigated the gene expression of antral gastrin and somatostatin in Helicobacter pylori-infected subjects. Twelve asymptomatic men with normal endoscopic findings participated in this study, four of whom were infected with H. pylori. METHODS Biopsy specimens of the gastric mucosa were obtained after subjects had fasted overnight. Serum gastrin levels, antral gastrin and somatostatin content, and antral G- and D-cell densities also were measured. RESULTS Fasting serum gastrin levels were significantly higher in H. pylori-positive subjects than in H. pylori-negative subjects. There were no differences between groups in antral gastrin content, G-cell density, or gastrin mRNA levels. Antral somatostatin content, D-cell density, somatostatin mRNA levels, and the somatostatin mRNA:D-cell density ratio were significantly decreased in H. pylori-positive subjects. CONCLUSIONS Our results suggest that in addition to reduced antral D-cell density, a suppression of somatostatin synthesis in D-cells may have contributed to the decrease in antral somatostatin in H. pylori-infected subjects.

UI MeSH Term Description Entries
D008297 Male Males
D011706 Pyloric Antrum The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS). Antrum, Pyloric,Gastric Antrum,Antrum, Gastric,Antrums, Gastric,Antrums, Pyloric,Gastric Antrums,Pyloric Antrums
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
May 1994, Gut,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
March 1997, The Indian journal of medical research,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
October 1993, Scandinavian journal of gastroenterology,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
January 1999, The Korean journal of internal medicine,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
August 1996, Alimentary pharmacology & therapeutics,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
February 2001, Immunopharmacology and immunotoxicology,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
February 1990, The Journal of biological chemistry,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
September 1998, The American journal of physiology,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
October 1995, Annals of medicine,
M Sumii, and K Sumii, and A Tari, and H Kawaguchi, and G Yamamoto, and Y Takehara, and Y Fukino, and T Kamiyasu, and M Hamada, and T Tsuda
June 1997, Gastroenterology,
Copied contents to your clipboard!